BIO KOREA 2024 concludes a success

Development of obesity treatments and next-generation new drugs receive the most attention

BIO KOREA 2024, cohosted by the Korea Health Industry Development Institute (President: Soon-do Cha) and the Provincial Administration of Chungcheongbuk-do (Governer: Young-hwan Kim), concluded successfully on the 10th.

 

BIO KOREA 2024, which celebrates its 19th anniversary this year, was held for 3 days at COEX in Seoul under the theme of 'The Future of Biotechnology Innovation and Global Collaboration.

 

Pic of BIO KOREA 2024 event

At the event, participants shared the trends and prospects of innovative technologies that have recently attracted attention in the biohealth industry.

 

The event also provided opportunities for global companies, institutions, researchers, and investors needed for the successful development of these technologies to forge business partnerships.

 

55 countries, 707 companies, and over 30,000 people attended the event.

 

In a congratulatory speech at the opening ceremony, Minister of Health and Welfare Kyoo-HongChosaid, "We will continue to expand R&D support, create a mega fund, support exports, and foster specialized talent for the goal of making the leap and becoming a global biohealth hub.

 

We expect BIO KOREA to spark cooperation for open innovation for Korean innovative businesses with innovative technologies of the future generation to expand their presence in the global market.” The event included business partnering, investment fair, exhibition, and conference programs.

 

In the business partnering program, which had been expanded due to increased demand for meetings following the participation of leading domestic and international biohealth companies, more than 1,800 meetings were held over 3 days to explore various business opportunities such as finding new partners, discussing technology cooperation and joint research, technology transfer, and investment.

 

The number of overseas participants attending to discover excellent domestic technologies increased by about 25% from the previous year, and the number of meetings held increased by about 36% in the same period.

 

The number of overseas companies participating in the exhibition increased by 37% , and 81 local companies from 10 countries participated in the National Pavilion and actively discussed business opportunities with domestic companies.

 

The conference featured 11 sessions that introduced and shared the latest advances and technology trends in the biohealth industry, including next-generation drug discovery platforms, diabetes and obesity treatments, microbiomes, and global open innovation.

 

The conference hall was filled with attendees showing great interest in the special sessions on next-generation drug discovery platforms, diabetes and obesity drugs that are gaining explosive interest and demand, and AI new drug development.

 

KHIDI President Soon-Do Cha remarked, “Thanks to the interest and active participation of domestic and international companies, organizations, and stakeholders, the BIO KOREA 2024 has concluded smoothly.

 

We hope that BIO KOREA will continue to serve as the largest technology and business exchange venue in Korea where Korean companies can forge global partnerships and create new business opportunities."